Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia

Article

Abstract: Purpose: To study the current practice for assessing comorbidity in adults with 21-hydroxylase CAH a

Palabras claves:

21-hydroxylase deficiency, Co-morbidities, Congenital adrenal hyperplasia, outcome, registry

Autores:

Ahmed S.F., Ali S.R., Bachega T.A.S.S., Baronio F., Bonfig W., Bryce J., Ceccato F., Cools M., Costa E.C., Daniel E., Falhammar H., Guaragna-Filho G., Iotova V., Markosyan R., Miranda M.C., Richard J. Auchus, Righi B., Ross R.J., Russo G., Stancampiano M.R., Tomlinson J.W., T’Sjoen G.

Fuentes:

scopus